Scientist

This is the third and final post of a series (part 1 and part 2) on directed evolution. What do protein engineers actually produce using directed...

This is Part 4 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

This is Part 3 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

This is Part 2 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

This is Part 1 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

Last week we talked about Stem cell research getting the “green light” and this week we continue with our stem cell blog series. Biology has long...

One of Scientist’s most popular blog posts of last year was an infographic depicting American attitudes towards stem cell research. Part of that...

Since the National Human Genome Research Institute (NHGRI) initiated a program in 2004 to advance sequencing technology development, the resulting...

Next generation sequencing has reduced costs and increased the throughput, as compared to Sanger sequencing. Importantly, it has expanded the...

In the previous post, we saw the impetus behind the technological innovation that led to development of next generation sequencing. So, for...